Evidence map›Paper›PMID 36402225›Full record

ArticleJournal of molecular biology2023

The Integration of Proteome-Wide PTM Data with Protein Structural and Sequence Features Identifies Phosphorylations that Mediate 14-3-3 Interactions.

C M Egbert, L R Warr, K L Pennington, M M Thornton, A J Vaughan, S W Ashworth, M J Heaton, N English, M P Torres, J L Andersen

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

C M EgbertFritz B. Burns Cancer Research Laboratory, Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
L R WarrDepartment of Statistics, Brigham Young University, Provo, UT, USA.
K L PenningtonFritz B. Burns Cancer Research Laboratory, Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA; Department of Biological and Environmental Sciences, Longwood University, Farmville, VA, USA.
M M ThorntonDepartment of Computer Science, Brigham Young University, Provo, UT, USA.
A J VaughanFritz B. Burns Cancer Research Laboratory, Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
S W AshworthFritz B. Burns Cancer Research Laboratory, Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA.
M J HeatonDepartment of Statistics, Brigham Young University, Provo, UT, USA.
N EnglishQuantitative Bioscience Program, Georgia Institute of Technology, Atlanta, GA, USA.
M P TorresQuantitative Bioscience Program, Georgia Institute of Technology, Atlanta, GA, USA; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.
J L AndersenFritz B. Burns Cancer Research Laboratory, Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA. Electronic address: jandersen@chem.byu.edu.
Brigham Young University · USGeorgia Institute of Technology · USQuantitative BioSciences · US

Funding

G gamma N-terminal tails as regulators of G protein signalingR01GM117400 · NIGMS · GEORGIA INSTITUTE OF TECHNOLOGY · PI TORRES, MATT PHILLIP · 2016 to 2019
$1.2M
The Regulation and Function of the Ubiquitin-Sensing Kinase TNK1R01GM147310 · NIGMS · UNIVERSITY OF UTAH · PI ANDERSEN, JOSHUA LYON · 2022 to 2024
$957k
NIGMS NIH HHS R01 GM117400NIGMS NIH HHS R01 GM147310
6 · The paper itself

Abstract

14-3-3s are abundant proteins that regulate essentially all aspects of cell biology, including cell cycle, motility, metabolism, and cell death. 14-3-3s work by docking to phosphorylated Ser/Thr residues on a large network of client proteins and modulating client protein function in a variety of ways. In recent years, aided by improvements in proteomics, the discovery of 14-3-3 client proteins has far outpaced our ability to understand the biological impact of individual 14-3-3 interactions. The rate-limiting step in this process is often the identification of the individual phospho-serines/threonines that mediate 14-3-3 binding, which are difficult to distinguish from other phospho-sites by sequence alone. Furthermore, trial-and-error molecular approaches to identify these phosphorylations are costly and can take months or years to identify even a single 14-3-3 docking site phosphorylation. To help overcome this challenge, we used machine learning to analyze predictive features of 14-3-3 binding sites. We found that accounting for intrinsic protein disorder and the unbiased mass spectrometry identification rate of a given phosphorylation significantly improves the identification of 14-3-3 docking site phosphorylations across the proteome. We incorporated these features, coupled with consensus sequence prediction, into a publicly available web app, called "14-3-3 site-finder". We demonstrate the strength of this approach through its ability to identify 14-3-3 binding sites that do not conform to the loose consensus sequence of 14-3-3 docking phosphorylations, which we validate with 14-3-3 client proteins, including TNK1, CHEK1, MAPK7, and others. In addition, by using this approach, we identify a phosphorylation on A-kinase anchor protein-13 (AKAP13) at Ser2467 that dominantly controls its interaction with 14-3-3.

Indexed as

14-3-3 ProteinsProtein Interaction MapsBinding SitesFetal ProteinsHumansMachine LearningMitogen-Activated Protein Kinase 7PhosphorylationProtein-Tyrosine KinasesProteomeSerineThreonine14-3-3 ProteinsFetal ProteinsMAPK7 protein, humanMitogen-Activated Protein Kinase 7Protein-Tyrosine KinasesProteomeSerineThreonineTNK1 protein, human14-3-3AKAP13phosphorylationPTMsignalingweb tool

Identifiers

PMID36402225
PMCPMC10099770
OpenAlexW4309436619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.